Cardiac contractility modulation (CCM) is an innovative device-based therapy designed to enhance myocardial performance in patients with heart failure, particularly those with reduced ejection ...

Heart failure (HF) continues to be a major cause of morbidity and mortality 1. The use of electrical therapies such as cardiac resynchronization therapy (CRT) supplementing guideline directed medical ...

Consultant Fee/Honoraria/Speaker's Bureau - AstraZenca; Bayer AG; Bristol-Myers Squibb; Medtronic; Merck/Schering Plough; Boston Scientific Corporation; Daiichi-Sankyo/Elil Lilly and Company; Edwards ...

Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients: Receive the the ...

OMAHA, Neb. (WOWT) — A man’s incredible response to a new congestive heart failure therapy at Nebraska Medicine is offering hope for others suffering from the condition. Steve Turner, 75, of Elk Horn, ...

SIOUX CITY (KTIV) - Brad Hedlund has been in and out of appointments with cardiologists dealing with heart failure over the last decade. Hedlund explained his symptoms as “I had no energy. I had no ...

MINNEAPOLIS -- The novel dual-function cardiac contractility modulation-defibrillator (CCM-D) for heart failure with reduced ejection fraction (HFrEF) had favorable early results in the Integra-D ...

CLEVELAND, Ohio — The Cleveland Clinic said that it implanted a dual-function cardiac device in a patient as part of a clinical trial this week, marking the first time this has been done in the world.

"Medical Journeys" is a set of clinical resources reviewed by physicians, meant for the medical team as well as the patients they serve. Each episode of this journey through a disease state contains ...

Please provide your email address to receive an email when new articles are posted on . A novel implantable cardioverter defibrillator platform may benefit patients with HF not eligible for cardiac ...

Heart disease is expected to spike over the next 25 years among younger women, according to a new warning from the American Heart Association. Doctors at Jefferson Einstein Hospital are now using an ...